ArticleJournal of diabetes science and technology2022

Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.

Morten Hasselstrøm Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.